1 Min Read
Jan 16 (Reuters) - EyeGene Inc :
* Says it received patent on Jan. 15, for vaccine for inducing an improved immune reaction
* Patent number is 10-2014-7010000
Source text in Korean: goo.gl/qcYcuV
Further company coverage: (Beijing Headline News)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.